BASILEA PHARM.NA SF 1 earnings per share and revenue

PK5 earnings per share for the last semiannual are 1.67 EUR whereas the estimation was 1.21 EUR which accounts for 37.61% surprise. Company revenue for the same period amounts to 79.23 M EUR despite the estimated figure of 110.18 M EUR. Estimated earnings per share for the next semiannual are 3.45 EUR, and revenue is expected to reach 137.10 M EUR. Also watch annual changes over time to get a bigger picture of PK5 earnings per share and revenue dynamics.